Lars Gullestad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lars Gullestad has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Arne Yndestad
Research Institute for Internal Medicine, Rikshospitalet University Hospital, University of Oslo , N-0027, Oslo
2 shared publications - Jan Kristian Damås
Research Institute for Internal Medicine, Rikshospitalet University Hospital, University of Oslo, Oslo, Norway
2 shared publications Odd Geiran
2 shared publicationsPål Aukrust
Research Institute for Internal Medicine, Medical Department, Rikshospitalet, Oslo, Norway
2 shared publications- Pål Aukrust
Faculty of Medicine, University of Oslo, 0318 Oslo, Norway
2 shared publications Steinar Madsen
2 shared publications
Latest Publications
- 1 March 2007
- Vol. 127 (5)
[Diuretics not the first-choice-drug in chronic heart failure].
- Open Access
Full Length Article
- 1 June 2005
- Published by Elsevier in The American Journal of Cardiology
- Vol. 95 (11) , 17-23
Review of Trials in Chronic Heart Failure Showing Broad-Spectrum Anti-Inflammatory Approaches
- 1 June 2005
- Published by Elsevier in The American Journal of Cardiology
- Vol. 95 (11) , 17-23
Review of Trials in Chronic Heart Failure Showing Broad-Spectrum Anti-Inflammatory Approaches
- 22 April 2004
- Vol. 124 (8) , 1107-10
[Modern diagnosis and treatment of heart failure].
Chronic heart failure is a prevalent condition associated with high morbidity, high mortality and reduced quality of life. Chronic heart failure is the end-stage of various forms of heart disease. The prognosis is poor, worse than for patients with various forms of cancer. The diagnosis of heart failure is made in the presence of multiple symptoms and signs combined with objective evidence of cardiac dysfunction. Treatment consists of pharmacological as well as non-pharmacological approaches. ACE inhibitors and beta-blockers are the basis of treatment, while diuretics and other medications are given on an individual basis. The aim of treatment is to reduce progression of the underlying disease and to reduce mortality and morbidity.
- 22 April 2004
- Vol. 124 (8) , 1107-10
[Modern diagnosis and treatment of heart failure].
Chronic heart failure is a prevalent condition associated with high morbidity, high mortality and reduced quality of life. Chronic heart failure is the end-stage of various forms of heart disease. The prognosis is poor, worse than for patients with various forms of cancer. The diagnosis of heart failure is made in the presence of multiple symptoms and signs combined with objective evidence of cardiac dysfunction. Treatment consists of pharmacological as well as non-pharmacological approaches. ACE inhibitors and beta-blockers are the basis of treatment, while diuretics and other medications are given on an individual basis. The aim of treatment is to reduce progression of the underlying disease and to reduce mortality and morbidity.
- 1 March 2004
- Published by Bentham Science Publishers Ltd. in Vascular Disease Prevention
- Vol. 1 (1) , 17-31
Atherosclerotic Plaque Stabilization - Potential Role for Immunomodulatory Therapy
- 1 March 2004
- Published by Bentham Science Publishers Ltd. in Vascular Disease Prevention
- Vol. 1 (1) , 17-31
Atherosclerotic Plaque Stabilization - Potential Role for Immunomodulatory Therapy
- 1 January 2004
- Published by Elsevier in American Heart Journal
- Vol. 147 (1) , 49-54
Predictors of exercise capacity and the impact of angiographic coronary artery disease in heart transplant recipients
- 1 January 2004
- Published by Elsevier in American Heart Journal
- Vol. 147 (1) , 49-54
Predictors of exercise capacity and the impact of angiographic coronary artery disease in heart transplant recipients
- 6 March 2003
- Vol. 123 (5) , 651-2
[Use of beta-blockaders in heart failure].
- 1 November 2002
- Published by Elsevier in American Heart Journal
- Vol. 144 (5) , 847-850
Effect of thalidomide in patients with chronic heart failure
- 1 November 2002
- Published by Elsevier in American Heart Journal
- Vol. 144 (5) , 847-850
Effect of thalidomide in patients with chronic heart failure